Louis Edward Tamayo
Chief Financial Officer · Lexeo Therapeutics, Inc.
- 2025
- Sep 28, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Louis Edward Tamayo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Nolan Townsend - $538K in LXEO purchases and sales in the last 12 months
- Narinder Pal Bhalla - $99K in LXEO purchases and sales in the last 12 months
- Jose Manuel Otero - $60K in LXEO purchases and sales in the last 12 months
- Eric Adler - $6K in LXEO purchases and sales in the last 12 months
- Jenny Robertson - $5K in LXEO purchases and sales in the last 12 months
- Tai Sandi See - $4K in LXEO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Louis Edward Tamayo?
Louis Edward Tamayo is a corporate insider, tracked as Chief Financial Officer of Lexeo Therapeutics, Inc. (LXEO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Louis Edward Tamayo submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Louis Edward Tamayo been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($41K) across all tracked filings.
